Everyone is encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You can also contact BioXcel Therapeutics, Inc. at 1-833-201 ...

Bipolar depression can feel endless, but evidence-based treatments and small steps can make recovery possible. When Sara F.

Vanda also sells sleep disorder drug Hetlioz, which reached the market in 2014, and relapsing multiple sclerosis treatment Ponvory, which was approved in 2021. The FDA is scheduled on Jan. 7 to decide ...

Weight gain is one of the most worrying side effects for young people taking certain medications for bipolar disorder. These medicines, known as second‑generation antipsychotics, are very effective at ...

If you’re living with bipolar disorder and standard treatments aren’t bringing relief, your provider might use the term “treatment-resistant.” It’s a label that can sound worryingly like “untreatable, ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) on Wednesday released topline exploratory efficacy data from the SERENITY At-Home Pivotal Phase 3 safety trial, which demonstrated that BXCL501 had continued ...

Shares of BioXcel Therapeutics rose after the company said it received positive comments from the FDA about its treatment of agitation associated with bipolar disorders or schizophrenia. The stock was ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The hallmark of bipolar ...

The Global Bipolar Disorder Mood Stabilizers Market size was valued at USD 2.22 Billion in 2025 and is expected to reach USD 2.64 Billion by 2032, growing at a compound annual growth rate (CAGR) of ...

ABSTRACT: Lithium has long been established as a first-line mood stabilizer in the treatment of bipolar disorder and treatment-resistant depression. In addition to its psychiatric applications, ...